Published in Vaccine Weekly, November 1st, 2006
Study 1: Liposomes show promise as an adjuvant for leishmaniasis vaccines.
"In this study the ability of recombinant gp63 entrapped in liposomes to induce immune response and protection against L. major infection in susceptible BALB/c mice was studied," scientists writing in the journal Vaccine report.
Liposomes containing rgp63 (Lip-rgp63) were prepared from egg lecithin and cholesterol using detergent solubilization method," explained Mahmoud R. Jaafari at Mashhad University of Medical Sciences. "Immunization of BALB/c mice with rgp63...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly